SILK - Silk Road Medical, Inc
46.99 0.00 (0.00%)
After hours: 4:00PM EST
| Previous Close | 47.11 |
| Open | 46.98 |
| Bid | 45.00 x 1100 |
| Ask | 49.97 x 1100 |
| Day's Range | 46.50 - 47.26 |
| 52 Week Range | 27.83 - 51.50 |
| Volume | 145,301 |
| Avg. Volume | 325,563 |
| Market Cap | 1.45B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.49 |
| Earnings Date | Feb 25, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49.33 |
- GlobeNewswire
Silk Road Medical to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020
SUNNYVALE, Calif., Feb. 13, 2020 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will.
- Newsfile
Silk Energy Announces Closing of Private Placement of Convertible Debentures and Corrects Prior News Release
Toronto, Ontario--(Newsfile Corp. - January 30, 2020) - Silk Energy Limited (CSE: SILK) (the "Company") is pleased to announce that it has closed two tranches of its previously announced private placement offering of convertible debentures (the "Convertible Debentures"). To correct and clarify the Company's news release of December 11, 2019, the Offering of Convertible Debentures is additional to, and separate from, the Company's ongoing offering of up to $2,000,000 of units.The Company intends to raise ...
- Newsfile
Silk Energy Announces Changes to the Board of Directors
Toronto, Ontario--(Newsfile Corp. - January 10, 2020) - Silk Energy Limited (CSE: SILK) (the "Company") announces the resignations of directors Jay Vieira and Herb Brugh, effective January 10th, 2020. The Company wishes to thank Messieurs Vieira and Brugh for their contributions to the Company and wishes them success in their future endeavours. New Directors The Company is pleased to announce that Bryan Emslie has been appointed as a director of the Company effective ...
- American City Business Journals
Last year's Bay Area IPO performances show why it pays to be an insider
Timing is everything: Here's a look at the big gap in returns for public and private investors in the best performing new Bay Area stocks from last year.
- Zacks
The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK
The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK
- Zacks
5 Best Performing IPOs of 2019
This year's IPOs performed impressively on the back of strong innovation and a solid balance sheet.
- GlobeNewswire
Silk Road Medical to Present at the 38th Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 19, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the.
- GlobeNewswire
Results Demonstrating Favorable Outcomes with TCAR vs. TF-CAS in Patients with Carotid Artery Stenosis Published in the Journal of the American Medical Association (JAMA)
SUNNYVALE, Calif., Dec. 17, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that.
- Insider Monkey
Hedge Funds Are Dumping Silk Road Medical, Inc. (SILK)
Does Silk Road Medical, Inc. (NASDAQ:SILK) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they […]
- Newsfile
Silk Energy Provides CSE Listing Update, Operational Update and Announces Expanded Financing
Toronto, Ontario--(Newsfile Corp. - December 11, 2019) - Silk Energy Limited (CSE: SILK) (the "Company") is pleased to provide an update with respect to its CSE listing application, its operations in Kazakhstan and its financing strategies. Conditional Listing Approval On December 9, 2019 the Company was issued a revised conditional approval letter (the "New Conditional Approval") by the Canadian Securities Exchange ("CSE") in respect of the Company's application for listing on the CSE. ...
- PR Newswire
Sight Sciences Appoints Erica Rogers to its Board of Directors
Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced the appointment of Erica Rogers to the company's board of directors.
- GlobeNewswire
Favorable Outcomes with TCAR vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
Updated Results of TCAR Surveillance Project Presented at 2019 VEITHsymposium NEW YORK, Nov. 22, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on.
- American City Business Journals
Norwest Venture Partners raises biggest fund as 'dry powder' in VC builds
The new fund from Palo Alto-based Norwest is a third larger than its previous one that was raised about 18 months ago. It is the firm's fifth of $1 billion or more in the past 10 years.
- GlobeNewswire
Silk Road Medical to Present at the Stifel 2019 Healthcare Conference
Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Stifel 2019 Healthcare Conference in New York, NY. Silk Road Medical’s management is scheduled to present on Tuesday, November 19 at 10:20 a.m. Eastern Time. Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact.
- Simply Wall St.
Health Check: How Prudently Does Silk Road Medical (NASDAQ:SILK) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- GlobeNewswire
Silk Road Medical Reports Third Quarter 2019 Financial Results
SUNNYVALE, Calif., Oct. 29, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Silk Road Medical, Inc. (SILK)
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades. Interest rates are paused at very low levels, and the risk of significant increases in the medium term seems low. Financing for transactions is freely available to good borrowers, […]
- GlobeNewswire
Silk Road Medical to Report Third Quarter 2019 Financial Results on October 29, 2019
SUNNYVALE, Calif., Oct. 14, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will.
- Newsfile
Silk Energy Update - Private Placement
Toronto, Ontario--(Newsfile Corp. - October 7, 2019) - SILK ENERGY LIMITED (CSE: SILK) (the "Company") is pleased to announce that it has closed on $446,247.45 of its $2.0 million non-brokered Private Placement (the "Offering"). The Offering is fully subscribed and the Company expects to close on the balance shortly. The $446,247.45 closed from the issuance of 2,974,983 units (the "Units") at the price of $0.15 per Unit. Each Unit consists of one common share ...
- Newsfile
Silk Energy Update - Completion of Reverse Take-Over
Toronto, Ontario--(Newsfile Corp. - September 5, 2019) - Further to its news release on July 10, 2019, SILK ENERGY LIMITED (CSE: SILK) (formerly Inspiration Mining Corporation) (the "Company") is pleased to announce the completion, effective on September 3, 2019, of its previously announced transaction with Silk Energy A.S. ("Silk Energy"), whereby the Company has acquired all of the issued and outstanding shares of Silk Energy by way of a reverse take-over (the "RTO"). ...
- MoneyShow
Silk Road Medical Targets Stroke Reduction
Based in Sunnyvale, California, Silk Road Medical (SILK) is a medical device company focused on reducing the risk of stroke and its devastating impact, explains Steve Silver, an analyst with Argus Research.
Motley FoolCould This Stroke-Prevention Specialist Be the Next Great Growth Stock?
This newly public company is growing at breakneck speed and has a massive opportunity ahead of it.
- GlobeNewswire
Silk Road Medical Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SUNNYVALE, Calif., Aug. 13, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact,.
- GlobeNewswire
Silk Road Medical Announces Pricing of Upsized Public Offering
Silk Road Medical, Inc. (SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an upsized secondary public offering of 4,200,000 shares of its common stock by certain selling stockholders at a public offering price of $39.50 per share. In addition, certain selling stockholders granted the underwriters a 30-day option to purchase up to an additional 630,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. Silk Road Medical will not receive any proceeds from the sale of shares of common stock by the selling stockholders.
